Market Place
Sourcing Support
PharmaMar Gets Approval of Zepzelca For Metastatic Small Cell Lung Cancer
09 Mar 2023 //
KALKINEMEDIA
PharmaMar initiates first human clinical trial of a new molecule, PM534
30 Dec 2022 //
PRESS RELEASE
PharmaMar leads the ONCOLIBERYX consortium together with four research centers
02 Dec 2022 //
PRESS RELEASE
PharmaMar says potential COVID-19 treatment shows efficacy against Omicron
10 Jan 2022 //
REUTERS
PharmaMar signs a new licensing and commercialization agreement with Eczacibasi
23 Dec 2021 //
PRNEWSWIRE
PharmaMar, Jazz Announce Initiation of Confirmatory Phase 3 Trial of Zepzelca
11 Dec 2021 //
PRNEWSWIRE
PharmaMar Partners with Lotus Pharmaceutical for lurbinectedin in Taiwan
11 Nov 2021 //
FIRSTWORDPHARMA
Spain`s PharmaMar posts 58% drop in 9-mth profit despite higher revenues
28 Oct 2021 //
REUTERS
PharmaMar announces the approval of ZepzelcaTM
30 Sep 2021 //
PRESS RELEASE
New Therapy to Treat Advanced SCLC,ZEPZELCA(lurbinectedin) Approved in Singapore
22 Sep 2021 //
PRNEWSWIRE
WHO grants the name ecubectedin to PharmaMar`s anti-tumor compound PM14
13 Sep 2021 //
ACROFAN
Google pushes cookie ban back, but pharma advertisers stay alert
28 Jul 2021 //
FIERCEPHARMA
German firm RauCon extend services to Asia by assisting Chinese pharma market
02 Jul 2021 //
BIOSPECTRUMASIA
Spain`s PharmaMar says Covid-19 treatment drug shows clinical efficacy in trials
25 May 2021 //
ECONOMICTIMES
PharmaMar announces abstracts to be presented at ASCO 2021
20 May 2021 //
MARKETSCREENER
Sylentis, PharmaMar Group, initiates a Phase I clinical trial with SYL1801
19 Mar 2021 //
PHARMAMAR
Sylentis, PharmaMar Group, announces the end of patient recruitment
05 Mar 2021 //
SYLENTIS
PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19
29 Jan 2021 //
PMLIVE
PharmaMar signs a licensing agreement with RPharm to commercialize Yondelis®
24 Dec 2020 //
PRESS RELEASE
Jazz Pharma’s SCLC drug fails to meet primary endpoint in combo trial
08 Dec 2020 //
PMLIVE
PharmaMar & Luye Pharma have started a clinical trial with lurbinectedin
04 Dec 2020 //
PRESS RELEASE
Jazz, PharmaMar say confirmatory study of Zepzelca misses main goal
03 Dec 2020 //
PRNEWSWIRE
STADA and PharmaMar sign agreement to commercialize Yondelis®
17 Nov 2020 //
ZAWYA
PharmaMar signs an agreement with Jazz for lurbinectedin in Canada
15 Oct 2020 //
FIRSTWORDPHARMA
PharmaMar plans phase III trial of cancer drug for COVID-19, shares jump
15 Oct 2020 //
REUTERS
PharmaMar signs a new agreement with Onko to commercialize Yondelis® in Turkey
10 Aug 2020 //
PRESS RELEASE
Pharma Mar S A : PharmaMar has filed lurbinectedin for Temporary Marketing
21 Jul 2020 //
MARKETSCREENER
Boryung , PharmaMar’s partner in South Korea, announces superior potent results
02 Jul 2020 //
PHARMAMAR.COM/WP-CONTENT/UPLOADS/2020/07
Jazz Pharma’s $1B bet pays off with accelerated lung cancer approval
17 Jun 2020 //
ENDPTS
PharmaMar and Key Oncologics have signed an. exclusive agreement Yondelis®
19 May 2020 //
PHARMAMAR
PharmaMar Has Announced That the Spanish Medicines Agency Aplidin® (Plitidepsin)
29 Apr 2020 //
YAHOO
PharmaMar signs an agreement with Immedica Pharma to market lurbinectedin
29 Apr 2020 //
MARKETSCREENER
PharmaMar Has Announced the Spanish Medicines Agency Has Authorized APLICOV-PC
27 Apr 2020 //
PR NEWSWIRE
PharmaMar & Jazz Announce FDA Acceptance & Priority Review of NDA Lurbinectedin
17 Feb 2020 //
PR NEWSWIRE
PharmaMar to supply Jazz with drug product under $1bn deal
16 Jan 2020 //
IN PHARMATECHNOLOGIST
Jazz rolls the dice on a billion-dollar gamble on a new drug for SCLC
19 Dec 2019 //
ENDPTS
PharmaMar files for FDA approval of small cell lung cancer drug
18 Dec 2019 //
FIERCE BIOTECH
PharmaMar files for FDA approval of small cell lung cancer drug
17 Dec 2019 //
PRESS RELEASE
Genomica, Huasin Science completes 1st CLART diagnostic equipment for China
30 Nov 2019 //
PHARMABIZ
Pharma Mar Gets Orphan Drug Designation For Lurbinectedin By Swiss Agency
26 Nov 2019 //
PRESS RELEASE
PharmaMar has presented results of its antitumor compounds trabectedin
19 Nov 2019 //
BIOSPACE
PharmaMar will submit NDA for lurbinectedin under accelerated approval in SCLC
19 Aug 2019 //
PR NEWSWIRE
Norgine rejoins ABPI after eight year absence
16 Feb 2017 //
PHARMATIMES
PharmaMar seeks European marketing approval for Aplidin for myeloma treatment
22 Sep 2016 //
PHARMABIZ
